EverSource Wealth Advisors »

Candel Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $262 25 10.50
2025-09-30 $439 86 5.10
2025-03-31 $215 38 5.66

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Value Etf Etf (VTV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Apple Stock (AAPL)
Praxis Impact Large Cap Value Etf Etf (PRXV)
iShares Gold Trust ETF Etf (IAU)
Nvidia Corporation Stock (NVDA)
Applied Matls Stock (AMAT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Tesla Stock (TSLA)
Vanguard Total Stock Market Etf Etf (VTI)
Amazon Stock (AMZN)
Broadcom Stock (AVGO)

View all positions for EverSource Wealth Advisors

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International
Sands Capital Ventures

View all funds holding Candel Therapeutics